Peer-reviewedCC BYFrontiers in medicine
Long-term upadacitinib treatment in a patient with atopic dermatitis, bullous pemphigoid, and alopecia areata: a case report and review of the literature
- 1Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila , ,
Related
- Clinical Response to Upadacitinib in Treatment-Experienced Patients With Atopic Dermatitis: A Case Series From Latin America.
- Long-Term Disease Control During Continuous Treatment with Upadacitinib and Baricitinib for Moderate-to-Severe Atopic Dermatitis: a Real-World Monocentric Retrospective Study
- Comparative Efficacy of Ritlecitinib, Baricitinib, and Upadacitinib in Adolescents With Severe Alopecia Areata: A Bayesian Network Meta‑Analysis
- Vitiligo developing during dupilumab treatment in a child with atopic dermatitis: a case report and literature review
- Subcorneal Pustular Dermatosis as a Complication of Upadacitinib Therapy in a Patient with Atopic Dermatitis: A Case Report
BibTeX
@article{triolo2026longterm,
title = {{Long-term upadacitinib treatment in a patient with atopic dermatitis, bullous pemphigoid, and alopecia areata: a case report and review of the literature}},
author = {Sara Triolo and Manfredo Bruni and Lina Maria Magnanimi and Andrea De Berardinis and Simone Mozzato and Mirco Mastrangelo and Cristina Pellegrini and Maria Esposito},
journal = {Frontiers in medicine},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13661302},
note = {CC BY},
}
RIS
TY - JOUR
TI - Long-term upadacitinib treatment in a patient with atopic dermatitis, bullous pemphigoid, and alopecia areata: a case report and review of the literature
AU - Sara Triolo
AU - Manfredo Bruni
AU - Lina Maria Magnanimi
AU - Andrea De Berardinis
AU - Simone Mozzato
AU - Mirco Mastrangelo
AU - Cristina Pellegrini
AU - Maria Esposito
PY - 2026
DA - 2026/10/16
JO - Frontiers in medicine
UR - https://europepmc.org/article/PMC/PMC13661302
SN - 2296-858X
ER -